1 Sharon Cardiovascular Unit and the Research Division of Infectious Diseases, Children's Hospital Medical Center and the Department of Pediatrics, Harvard Medical School
Sixteen patients who fit the diagnostic criteria of endocardial fibroelastosis were investigated by means of mumps skin tests and serum assays of mumps hemagglutination-inhibiting antibodies. No relationship was found between the clinical entity, endocardial fibroelastosis, and either mumps-specific antibodies or delayed cutaneous hypersensitivity to the mumps virus.
Submitted on August 2, 1965
This article has been cited by other articles:
![]() |
J. Ni, N. E. Bowles, Y.-H. Kim, G. Demmler, D. Kearney, J. T. Bricker, and J. A. Towbin Viral Infection of the Myocardium in Endocardial Fibroelastosis: Molecular Evidence for the Role of Mumps Virus as an Etiologic Agent Circulation, January 7, 1997; 95(1): 133 - 139. [Abstract] [Full Text] |
||||
![]() |
M. Katz Is There Mumps Embryopathy?: An Unanswered Question Clinical Pediatrics, June 1, 1967; 6(6): 321 - 322. [PDF] |
||||